Key regions: Australia, United States, India, Europe, China
The Digestive & Intestinal Remedies (Pharmacies) market in Southern Europe is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Southern Europe have shifted towards natural and herbal remedies. Consumers are increasingly seeking products that are gentle on their digestive system and have fewer side effects. This preference for natural remedies is driven by a growing awareness of the potential risks and adverse effects associated with synthetic medications. Additionally, consumers are becoming more health-conscious and are opting for preventive measures to maintain their digestive health. Trends in the market include the rising popularity of probiotics and digestive enzymes. Probiotics are live bacteria and yeasts that are beneficial for the digestive system. They help restore the natural balance of bacteria in the gut and promote healthy digestion. Digestive enzymes, on the other hand, aid in the breakdown of food and improve nutrient absorption. These trends are driven by a growing understanding of the importance of gut health in overall well-being. Local special circumstances in Southern Europe also contribute to the development of the Digestive & Intestinal Remedies (Pharmacies) market. The region has a rich culinary tradition, with a focus on flavorful and often heavy meals. This can lead to digestive issues such as indigestion, bloating, and heartburn. As a result, there is a high demand for remedies that can alleviate these symptoms and promote digestive comfort. Underlying macroeconomic factors further support the growth of the Digestive & Intestinal Remedies (Pharmacies) market in Southern Europe. The region has a large aging population, which is more susceptible to digestive issues. As the population continues to age, the demand for digestive remedies is expected to increase. Additionally, Southern Europe is a popular tourist destination, attracting millions of visitors each year. Tourists often experience digestive discomfort due to changes in diet and lifestyle, creating a need for remedies that can provide relief. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Southern Europe is developing rapidly due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards natural remedies, the popularity of probiotics and digestive enzymes, the region's culinary traditions, the aging population, and the influx of tourists all contribute to the growth of this market.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
